6S0S

The crystal structure of kanamycin B dioxygenase (KanJ) from Streptomyces kanamyceticus in complex with nickel, ribostamycin B and 2-oxoglutarate


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 0.204 
  • R-Value Work: 0.173 
  • R-Value Observed: 0.174 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.4 of the entry. See complete history


Literature

A study on the structure, mechanism, and biochemistry of kanamycin B dioxygenase (KanJ)-an enzyme with a broad range of substrates.

Mrugala, B.Milaczewska, A.Porebski, P.J.Niedzialkowska, E.Guzik, M.Minor, W.Borowski, T.

(2021) FEBS J 288: 1366-1386

  • DOI: https://doi.org/10.1111/febs.15462
  • Primary Citation of Related Structures:  
    6S0R, 6S0S, 6S0T, 6S0U, 6S0V, 6S0W

  • PubMed Abstract: 

    Kanamycin A is an aminoglycoside antibiotic isolated from Streptomyces kanamyceticus and used against a wide spectrum of bacteria, including Mycobacterium tuberculosis. Biosynthesis of kanamycin involves an oxidative deamination step catalyzed by kanamycin B dioxygenase (KanJ), thereby the C2' position of kanamycin B is transformed into a keto group upon release of ammonia. Here, we present for the first time, structural models of KanJ with several ligands, which along with the results of ITC binding assays and HPLC activity tests explain substrate specificity of the enzyme. The large size of the binding pocket suggests that KanJ can accept a broad range of substrates, which was confirmed by activity tests. Specificity of the enzyme with respect to its substrate is determined by the hydrogen bond interactions between the methylamino group of the antibiotic and highly conserved Asp134 and Cys150 as well as between hydroxyl groups of the substrate and Asn120 and Gln80. Upon antibiotic binding, the C terminus loop is significantly rearranged and Gln80 and Asn120, which are directly involved in substrate recognition, change their conformations. Based on reaction energy profiles obtained by density functional theory (DFT) simulations, we propose a mechanism of ketone formation involving the reactive Fe IV  = O and proceeding either via OH rebound, which yields a hemiaminal intermediate or by abstraction of two hydrogen atoms, which leads to an imine species. At acidic pH, the latter involves a lower barrier than the OH rebound, whereas at basic pH, the barrier leading to an imine vanishes completely. DATABASES: Structural data are available in PDB database under the accession numbers: 6S0R, 6S0T, 6S0U, 6S0W, 6S0V, 6S0S. Diffraction images are available at the Integrated Resource for Reproducibility in Macromolecular Crystallography at http://proteindiffraction.org under DOIs: 10.18430/m36s0t, 10.18430/m36s0u, 10.18430/m36s0r, 10.18430/m36s0s, 10.18430/m36s0v, 10.18430/m36s0w. A data set collection of computational results is available in the Mendeley Data database under DOI: 10.17632/sbyzssjmp3.1 and in the ioChem-BD database under DOI: 10.19061/iochem-bd-4-18.


  • Organizational Affiliation

    Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Krakow, Poland.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Kanamycin B dioxygenase
A, B, C, D, E
A, B, C, D, E, F
288Streptomyces kanamyceticusMutation(s): 0 
Gene Names: kanJkacB
EC: 1.14.11.37
UniProt
Find proteins for Q6L732 (Streptomyces kanamyceticus)
Explore Q6L732 
Go to UniProtKB:  Q6L732
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ6L732
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
RIO
Query on RIO

Download Ideal Coordinates CCD File 
AA [auth F]
I [auth A]
L [auth B]
P [auth C]
T [auth D]
AA [auth F],
I [auth A],
L [auth B],
P [auth C],
T [auth D],
W [auth E]
RIBOSTAMYCIN
C17 H34 N4 O10
NSKGQURZWSPSBC-VVPCINPTSA-N
AKG
Query on AKG

Download Ideal Coordinates CCD File 
H [auth A]
K [auth B]
O [auth C]
S [auth D]
V [auth E]
H [auth A],
K [auth B],
O [auth C],
S [auth D],
V [auth E],
Z [auth F]
2-OXOGLUTARIC ACID
C5 H6 O5
KPGXRSRHYNQIFN-UHFFFAOYSA-N
NI
Query on NI

Download Ideal Coordinates CCD File 
G [auth A]
J [auth B]
N [auth C]
R [auth D]
U [auth E]
G [auth A],
J [auth B],
N [auth C],
R [auth D],
U [auth E],
Y [auth F]
NICKEL (II) ION
Ni
VEQPNABPJHWNSG-UHFFFAOYSA-N
CL
Query on CL

Download Ideal Coordinates CCD File 
M [auth B],
Q [auth C],
X [auth E]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
Experimental Data & Validation

Experimental Data

Unit Cell:
Length ( Å )Angle ( ˚ )
a = 50.083α = 90
b = 184.582β = 94.97
c = 110.333γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
HKL-3000data reduction
HKL-3000data scaling
HKL-3000phasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Polish National Science CentrePoland2014/15/B/NZ1/03331
National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI)United StatesR01-GM117325-01

Revision History  (Full details and data files)

  • Version 1.0: 2020-07-08
    Type: Initial release
  • Version 1.1: 2020-11-25
    Changes: Database references, Derived calculations
  • Version 1.2: 2021-02-24
    Changes: Database references
  • Version 1.3: 2022-03-30
    Changes: Author supporting evidence, Database references
  • Version 1.4: 2024-01-24
    Changes: Data collection, Refinement description